Likewise, our immunohistochemistry (IHC) analysis of tumors from a cohort of 501 ERα-positive breast tumors revealed that high expression of FOXM1 protein was associated with a much poorer patient survival (Figure 1D). Here, FOXM1 is linked to breast neoplasm.